July 1, 2017

A Breast Cancer Gene Signature for Indolent Disease

PUBLICATION: 
Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub 2008 Sep 26.

AUTHORS: 
Leonie J.M.J. Delahaye, Caroline A. Drukker, Christa Dreezen, Anke Witteveen, Bob Chan, Mireille Snel, Inès J. Beumer, Rene Bernards, M. William Audeh, Laura J. van’t Veer, Annuska M. Glas

SUMMARY: 
An Ultralow Risk development paper. In an independent validation cohort, we show that patients with indolent breast cancer had 100% breast cancer-specific survival at 15 years of follow-up.

Read more: A Breast Cancer Gene Signature… Delahaye et al_Breast Cancer Res Treat. 2017